Avoid common mistakes on your manuscript.
Correction to: BMC Cancer
https://doi.org/10.1186/s12885-018-5200-1
Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.
-
Originally published name:
-
Nicholas Nicholas G. Nickols
-
-
Correct name:
-
Nicholas G. Nickols
-
Reference
Calais, et al. Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]. BMC Cancer. 2018;19:18. https://doi.org/10.1186/s12885-018-5200-1.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Calais, J., Czernin, J., Fendler, W.P. et al. Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]. BMC Cancer 19, 97 (2019). https://doi.org/10.1186/s12885-019-5297-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12885-019-5297-x